Platinum containing regimens for triple-negative breast cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Platinum Containing Regimens for Triple-negative Breast Cancer." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452261/all/Platinum_containing_regimens_for_triple_negative_breast_cancer.
Platinum containing regimens for triple-negative breast cancer. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/452261/all/Platinum_containing_regimens_for_triple_negative_breast_cancer. Accessed March 10, 2025.
Platinum containing regimens for triple-negative breast cancer. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/452261/all/Platinum_containing_regimens_for_triple_negative_breast_cancer
Platinum Containing Regimens for Triple-negative Breast Cancer [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452261/all/Platinum_containing_regimens_for_triple_negative_breast_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Platinum containing regimens for triple-negative breast cancer
ID - 452261
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452261/all/Platinum_containing_regimens_for_triple_negative_breast_cancer
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -